CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation

Biochemical and Biophysical Research Communications

Volumn 478, Issue 2, 2016, Pages 838-844

  Yuan, Hua ^a   Li, Xuemei ^b   Zhang, Xiuying ^a   Kang, Rui ^c   Tang, Daolin ^a,c,d  

^a JILIN UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

CISD1; Ferroptosis; Iron sulfur proteins; Lipid peroxidation; Mitochondria

Indexed keywords

ANTINEOPLASTIC AGENT; CDGSH IRON SULFUR DOMAIN 1 PROTEIN; CELL MEMBRANE PROTEIN; ERASTIN; FERROUS ION; GLUTATHIONE; IRON CHELATING AGENT; IRON SULFUR PROTEIN; MALONALDEHYDE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PIOGLITAZONE; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; APOPTOSIS REGULATORY PROTEIN; CISD1 PROTEIN, HUMAN; DEFEROXAMINE; IRON; MITOCHONDRIAL PROTEIN; PIPERAZINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; FERROPTOSIS; GENE SILENCING; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IRON METABOLISM; IRON TRANSPORT; LIPID PEROXIDATION; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; AGONISTS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; METABOLISM; OXIDATIVE STRESS;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DEFEROXAMINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; IRON; IRON CHELATING AGENTS; LIPID PEROXIDATION; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; PIPERAZINES; THIAZOLIDINEDIONES;

EID: 84995640115     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.08.034     Document Type: Article

References (46)

1. [1] Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., Morrison, B. 3rd, Stockwell, B.R., Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149 (2012), 1060–1072.
2. [2] Jiang, L., Kon, N., Li, T., Wang, S.J., Su, T., Hibshoosh, H., Baer, R., Gu, W., Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520 (2015), 57–62.
3. [3] Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., Tang, D., Ferroptosis: process and function. Cell Death Differ. 23 (2016), 369–379.
4. [4] Yang, W.S., Stockwell, B.R., Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26 (2016), 165–176.
5. [5] Yang, W.S., SriRamaratnam, R., Welsch, M.E., Shimada, K., Skouta, R., Viswanathan, V.S., Cheah, J.H., Clemons, P.A., Shamji, A.F., Clish, C.B., Brown, L.M., Girotti, A.W., Cornish, V.W., Schreiber, S.L., Stockwell, B.R., Regulation of ferroptotic cancer cell death by GPX4. Cell 156 (2014), 317–331.
6. [6] Friedmann Angeli, J.P., Schneider, M., Proneth, B., Tyurina, Y.Y., Tyurin, V.A., Hammond, V.J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., Basavarajappa, D., Radmark, O., Kobayashi, S., Seibt, T., Beck, H., Neff, F., Esposito, I., Wanke, R., Forster, H., Yefremova, O., Heinrichmeyer, M., Bornkamm, G.W., Geissler, E.K., Thomas, S.B., Stockwell, B.R., O'Donnell, V.B., Kagan, V.E., Schick, J.A., Conrad, M., Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16 (2014), 1180–1191.
7. [7] Matsushita, M., Freigang, S., Schneider, C., Conrad, M., Bornkamm, G.W., Kopf, M., T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 212 (2015), 555–568.
8. [8] Yu, Y., Xie, Y., Cao, L., Yang, L., Yang, M., Lotze, M.T., Zeh, H.J., Kang, R., Tang, D., The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol. Cell Oncol., 2, 2015, e1054549.
9. [9] Shimada, K., Skouta, R., Kaplan, A., Yang, W.S., Hayano, M., Dixon, S.J., Brown, L.M., Valenzuela, C.A., Wolpaw, A.J., Stockwell, B.R., Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat. Chem. Biol. 12 (2016), 497–503.
10. [10] Sun, X., Ou, Z., Xie, M., Kang, R., Fan, Y., Niu, X., Wang, H., Cao, L., Tang, D., HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene 34 (2015), 5617–5625.
11. [11] Geldenhuys, W.J., Leeper, T.C., Carroll, R.T., mitoNEET as a novel drug target for mitochondrial dysfunction. Drug Discov. Today 19 (2014), 1601–1606.
12. [12] Colca, J.R., McDonald, W.G., Waldon, D.J., Leone, J.W., Lull, J.M., Bannow, C.A., Lund, E.T., Mathews, W.R., Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe. Am. J. Physiol. Endocrinol. Metab. 286 (2004), E252–E260.
13. [13] Wiley, S.E., Murphy, A.N., Ross, S.A., van der Geer, P., Dixon, J.E., MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 5318–5323.
14. [14] Paddock, M.L., Wiley, S.E., Axelrod, H.L., Cohen, A.E., Roy, M., Abresch, E.C., Capraro, D., Murphy, A.N., Nechushtai, R., Dixon, J.E., Jennings, P.A., MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 14342–14347.
15. [15] Wiley, S.E., Paddock, M.L., Abresch, E.C., Gross, L., van der Geer, P., Nechushtai, R., Murphy, A.N., Jennings, P.A., Dixon, J.E., The outer mitochondrial membrane protein mitoNEET contains a novel redox-active 2Fe-2S cluster. J. Biol. Chem. 282 (2007), 23745–23749.
16. [16] Tamir, S., Paddock, M.L., Darash-Yahana-Baram, M., Holt, S.H., Sohn, Y.S., Agranat, L., Michaeli, D., Stofleth, J.T., Lipper, C.H., Morcos, F., Cabantchik, I.Z., Onuchic, J.N., Jennings, P.A., Mittler, R., Nechushtai, R., Structure-function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease. Biochim. Biophys. Acta 1853 (2015), 1294–1315.
17. [17] Kusminski, C.M., Holland, W.L., Sun, K., Park, J., Spurgin, S.B., Lin, Y., Askew, G.R., Simcox, J.A., McClain, D.A., Li, C., Scherer, P.E., MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat. Med. 18 (2012), 1539–1549.
18. [18] Kusminski, C.M., Chen, S., Ye, R., Sun, K., Wang, Q.A., Spurgin, S.B., Sanders, P.E., Brozinick, J.T., Geldenhuys, W.J., Li, W.H., Unger, R.H., Scherer, P.E., MitoNEET-parkin effects in pancreatic alpha- and beta-cells, cellular survival, and intrainsular cross talk. Diabetes 65 (2016), 1534–1555.
19. [19] Kusminski, C.M., Park, J., Scherer, P.E., MitoNEET-mediated effects on browning of white adipose tissue. Nat. Commun., 5, 2014, 3962.
20. [20] Bai, F., Morcos, F., Sohn, Y.S., Darash-Yahana, M., Rezende, C.O., Lipper, C.H., Paddock, M.L., Song, L., Luo, Y., Holt, S.H., Tamir, S., Theodorakis, E.A., Jennings, P.A., Onuchic, J.N., Mittler, R., Nechushtai, R., The Fe-S cluster-containing NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 3698–3703.
21. [21] Sohn, Y.S., Tamir, S., Song, L., Michaeli, D., Matouk, I., Conlan, A.R., Harir, Y., Holt, S.H., Shulaev, V., Paddock, M.L., Hochberg, A., Cabanchick, I.Z., Onuchic, J.N., Jennings, P.A., Nechushtai, R., Mittler, R., NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 14676–14681.
22. [22] Lipper, C.H., Paddock, M.L., Onuchic, J.N., Mittler, R., Nechushtai, R., Jennings, P.A., Cancer-Related NEET proteins transfer 2Fe-2S clusters to anamorsin, a protein required for cytosolic iron-sulfur cluster biogenesis. PLoS One, 10, 2015, e0139699.
23. [23] Salem, A.F., Whitaker-Menezes, D., Howell, A., Sotgia, F., Lisanti, M.P., Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance. Cell Cycle 11 (2012), 4174–4180.
24. [24] Tang, D., Kang, R., Livesey, K.M., Cheh, C.W., Farkas, A., Loughran, P., Hoppe, G., Bianchi, M.E., Tracey, K.J., Zeh, H.J. 3rd, Lotze, M.T., Endogenous HMGB1 regulates autophagy. J. Cell Biol. 190 (2010), 881–892.
25. [25] Xie, Y., Song, X., Sun, X., Huang, J., Zhong, M., Lotze, M.T., Zeh, H.J. 3rd, Kang, R., Tang, D., Identification of baicalein as a ferroptosis inhibitor by natural product library screening. Biochem. Biophys. Res. Commun. 473 (2016), 775–780.
26. [26] Yang, W.S., Stockwell, B.R., Ferroptosis: Death by Lipid Peroxidation. Trends Cell Biol. 26 (2016), 165–176.
27. [27] Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., Tang, D., Ferroptosis: process and function. Cell Death Differ. 23 (2016), 369–379.
28. [28] Zuris, J.A., Harir, Y., Conlan, A.R., Shvartsman, M., Michaeli, D., Tamir, S., Paddock, M.L., Onuchic, J.N., Mittler, R., Cabantchik, Z.I., Jennings, P.A., Nechushtai, R., Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 13047–13052.
29. [29] Rouault, T.A., Mammalian iron-sulphur proteins: novel insights into biogenesis and function. Nat. Rev. Mol. Cell Biol. 16 (2015), 45–55.
30. [30] Dixon, S.J., Stockwell, B.R., The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10 (2014), 9–17.
31. [31] Muckenthaler, M.U., Galy, B., Hentze, M.W., Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28 (2008), 197–213.
32. [32] Stehling, O., Lill, R., The role of mitochondria in cellular iron-sulfur protein biogenesis: mechanisms, connected processes, and diseases. Cold Spring Harb. Perspect. Med. 3 (2013), 1–17.
33. [33] Shaw, G.C., Cope, J.J., Li, L., Corson, K., Hersey, C., Ackermann, G.E., Gwynn, B., Lambert, A.J., Wingert, R.A., Traver, D., Trede, N.S., Barut, B.A., Zhou, Y., Minet, E., Donovan, A., Brownlie, A., Balzan, R., Weiss, M.J., Peters, L.L., Kaplan, J., Zon, L.I., Paw, B.H., Mitoferrin is essential for erythroid iron assimilation. Nature 440 (2006), 96–100.
34. [34] Bresgen, N., Eckl, P.M., Oxidative stress and the homeodynamics of iron metabolism. Biomolecules 5 (2015), 808–847.
35. [35] Navarro, J.A., Botella, J.A., Metzendorf, C., Lind, M.I., Schneuwly, S., Mitoferrin modulates iron toxicity in a Drosophila model of Friedreich's ataxia. Free Radic. Biol. Med. 85 (2015), 71–82.
36. [36] Carroll, C.B., Zeissler, M.L., Chadborn, N., Gibson, K., Williams, G., Zajicek, J.P., Morrison, K.E., Hanemann, C.O., Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease. Neurochem. Int. 59 (2011), 73–80.
37. [37] Skouta, R., Dixon, S.J., Wang, J., Dunn, D.E., Orman, M., Shimada, K., Rosenberg, P.A., Lo, D.C., Weinberg, J.M., Linkermann, A., Stockwell, B.R., Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 136 (2014), 4551–4556.
38. [38] Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A.J., Yang, W.S., Fridman, D.J., Wolpaw, A.J., Smukste, I., Peltier, J.M., Boniface, J.J., Smith, R., Lessnick, S.L., Sahasrabudhe, S., Stockwell, B.R., RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447 (2007), 864–868.
39. [39] Magtanong, L., Ko, P.J., Dixon, S.J., Emerging roles for lipids in non-apoptotic cell death. Cell Death Differ. 23 (2016), 1099–1109.
40. [40] Liang, H., Yoo, S.E., Na, R., Walter, C.A., Richardson, A., Ran, Q., Short form glutathione peroxidase 4 is the essential isoform required for survival and somatic mitochondrial functions. J. Biol. Chem. 284 (2009), 30836–30844.
41. [41] Seiler, A., Schneider, M., Forster, H., Roth, S., Wirth, E.K., Culmsee, C., Plesnila, N., Kremmer, E., Radmark, O., Wurst, W., Bornkamm, G.W., Schweizer, U., Conrad, M., Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8 (2008), 237–248.
42. [42] Canli, O., Alankus, Y.B., Grootjans, S., Vegi, N., Hultner, L., Hoppe, P.S., Schroeder, T., Vandenabeele, P., Bornkamm, G.W., Greten, F.R., Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors. Blood 127 (2016), 139–148.
43. [43] Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., Tang, D., Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology 64 (2016), 488–500.
44. [44] Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., Tang, D., Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63 (2016), 173–184.
45. [45] Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M.T., Zeh, H.J. 3rd, Kang, R., Tang, D., Autophagy promotes ferroptosis by degradation of ferritin. Autophagy, 2016, 1–4.
46. [46] Faine, L.A., Rudnicki, M., Cesar, F.A., Heras, B.L., Bosca, L., Souza, E.S., Hernandes, M.Z., Galdino, S.L., Lima, M.C., Pitta, I.R., Abdalla, D.S., Anti-inflammatory and antioxidant properties of a new arylidene-thiazolidinedione in macrophages. Curr. Med. Chem. 18 (2011), 3351–3360.